Urovant Sciences GmbH
2Patents
2Active
2Granted
42Portfolio score
Filing activity: Jun 6, 2018 → Dec 5, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12102638B2 | Use of vibegron to treat overactive bladder | Human Necessities | 1 | Active |
| US12357636B2 | Vibegron for the treatment of overactive bladder symptoms | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.